Rejected
at 2:14 a.m. Nov, 01, 2023 ]
by
Ahmed7
Bulk Suggestion
Bulk ID:
skstroh/04.01.23-02:57PM
Author:
skstroh
Type of change:
Updated Tags
Rationale for change
Removed UW tag that didn't match content
No changes in fields
Text
Paroxysmal nocturnal hemoglobinuria (PNH) may be treated with {{c1::eculizumab}}, which is a terminal complement inhibitor
Extra
- Monoclonal antibody for C5 complement protein
- C5 is an important step in generating the membrane attack complex (MAC), formed of C5b + C6-C9
- Causes an increased risk of encapsulated bacterial infections
- C5 is an important step in generating the membrane attack complex (MAC), formed of C5b + C6-C9
- Causes an increased risk of encapsulated bacterial infections
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy
Empty field
Sketchy 2




Watch Intravascular Hemolytic Anemia: Non-MAHA DDx


Watch Hemolytic Uremic Syndrome



Watch Vaccination Schedule 2




Watch Intravascular Hemolytic Anemia: Non-MAHA DDx


Watch Hemolytic Uremic Syndrome



Watch Vaccination Schedule 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
Watch associated Bootcamp video - Normocytic Anemia: Paroxysmal Nocturnal Hemoglobinuria
Watch associated Bootcamp video - Complement Disorders
Watch associated Bootcamp video - Complement Disorders
OME
Additional Resources
Other:


One by one
Empty field
